Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle"

Circulation. 2016 Aug 30;134(9):e117-8. doi: 10.1161/CIRCULATIONAHA.116.024173.

Authors

Cathelijne E van der Bruggen¹, Chris M Happé¹, Marie-José Goumans¹, Harm Jan Bogaard¹, Anton Vonk Noordegraaf¹, Frances S de Man¹

Affiliation

¹ From VU University Medical Center/Institute of Cardiovascular Research, Pulmonology, Amsterdam, the Netherlands (C.E.E.v.d.B., C.M.H., H.J.B., A.V.N., F.S.d.M.); and Leiden University Medical Center, Molecular Cell Biology, Leiden, the Netherlands (M.J.G.).

PMID: 27572883
DOI: 10.1161/CIRCULATIONAHA.116.024173

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Morphogenetic Protein Receptors, Type II / genetics*
Familial Primary Pulmonary Hypertension
Heart Ventricles / metabolism*
Humans
Hypertension, Pulmonary / genetics
Mutation

Substances

Bone Morphogenetic Protein Receptors, Type II